Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.

Kang, Yixin; Zhou, Qian; Cui, Junchang

Kang, Yixin; Zhou, Qian; Cui, Junchang.

Affiliation

Kang Y; Department of Respiratory Diseases, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Zhou Q; Department of Respiratory Diseases, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing 100853, China; Department of Respiratory Diseases, People's Hospital of Hainan District, Wuhai 016000, China.
Cui J; Department of Respiratory Diseases, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing 100853, China. Electronic address: guoguoyoumeng@163.com.

J Glob Antimicrob Resist ; 27: 67-71, 2021 12.

Article in En | MEDLINE | ID: mdl-34428596

Subject(s)
Key words

Ceftazidime/avibactam; KPC; KPC-producing K. pneumoniae; Klebsiella pneumoniae carbapenemase; Monte Carlo simulation; Pharmacokinetic/pharmacodynamic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Klebsiella Infections / Ceftazidime / Pneumonia, Bacterial / Azabicyclo Compounds Type of study: Clinical_trials / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Glob Antimicrob Resist Year: 2021 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google